nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B
|
Sacco, Monica |
|
|
22 |
10 |
p. 2724-2738 |
artikel |
2 |
Annoucements
|
|
|
|
22 |
10 |
p. 2942 |
artikel |
3 |
A novel factor V compound heterozygous mutation associated with thrombosis (Y1961C; FV-Kanazawa, together with 1982_1983del)
|
Shimonishi, Naruto |
|
|
22 |
10 |
p. 2810-2822 |
artikel |
4 |
Characterization of recombinant factor IX fusion proteins enabling subcutaneous administration
|
Schön, Kathrin |
|
|
22 |
10 |
p. 2713-2723 |
artikel |
5 |
Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
|
Bonifay, Amandine |
|
|
22 |
10 |
p. 2910-2921 |
artikel |
6 |
Conformation of factor Xa in solution revealed by single-molecule spectroscopy
|
Stojanovski, Bosko M. |
|
|
22 |
10 |
p. 2767-2772 |
artikel |
7 |
Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice
|
Eldem, Irem |
|
|
22 |
10 |
p. 2681-2691 |
artikel |
8 |
Development and internal validation of the Cleveland Clinic Bleeding Model to predict major bleeding risk at admission in medical inpatients
|
Mittman, Benjamin G. |
|
|
22 |
10 |
p. 2855-2863 |
artikel |
9 |
Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL
|
Verbruggen, Bert |
|
|
22 |
10 |
p. 2745-2751 |
artikel |
10 |
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A
|
Hart, Christina |
|
|
22 |
10 |
p. 2692-2701 |
artikel |
11 |
Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor
|
Kelly, Claire |
|
|
22 |
10 |
p. 2900-2909 |
artikel |
12 |
External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2
|
Nishimoto, Yuji |
|
|
22 |
10 |
p. 2784-2796 |
artikel |
13 |
First impressions
|
Lisman, Ton |
|
|
22 |
10 |
p. 2677 |
artikel |
14 |
Full-dose rivaroxaban in patients with a history of bariatric surgery: bridging the knowledge gap through a phase 1 study
|
Leven, Cyril |
|
|
22 |
10 |
p. 2844-2854 |
artikel |
15 |
Hemophilia prophylaxis: defining outcome measures by regulatory agencies and ISTH
|
Visweshwar, Nathan |
|
|
22 |
10 |
p. 2939-2941 |
artikel |
16 |
Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate
|
Iorio, Alfonso |
|
|
22 |
10 |
p. 2739-2744 |
artikel |
17 |
Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis
|
Nagler, Bernhard |
|
|
22 |
10 |
p. 2773-2783 |
artikel |
18 |
Issue Information
|
|
|
|
22 |
10 |
p. e1-e5 |
artikel |
19 |
Keep it positive: loss of positive charge induced by R1205H von Willebrand factor change accelerates von Willebrand factor clearance through enhanced binding to macrophage clearance receptors LRP1 and SR-A1
|
Castaman, Giancarlo |
|
|
22 |
10 |
p. 2678-2680 |
artikel |
20 |
Positive antiphospholipid antibodies increase the risk of ischemic stroke in patients with atrial fibrillation
|
Hanarz, Maksymilian |
|
|
22 |
10 |
p. 2797-2809 |
artikel |
21 |
Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study
|
Blondon, Marc |
|
|
22 |
10 |
p. 2834-2843 |
artikel |
22 |
Prospective, international, multisite comparison of platelet isolation techniques for genome-wide transcriptomics: communication from the SSC of the ISTH
|
Banerjee, Meenakshi |
|
|
22 |
10 |
p. 2922-2934 |
artikel |
23 |
Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors
|
Schulman, Sam |
|
|
22 |
10 |
p. 2761-2766 |
artikel |
24 |
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
|
Levy, Jerrold H. |
|
|
22 |
10 |
p. 2889-2899 |
artikel |
25 |
R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI
|
Atiq, Ferdows |
|
|
22 |
10 |
p. 2752-2760 |
artikel |
26 |
Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients
|
Valeriani, Emanuele |
|
|
22 |
10 |
p. 2823-2833 |
artikel |
27 |
Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study
|
Gouin-Thibault, Isabelle |
|
|
22 |
10 |
p. 2864-2872 |
artikel |
28 |
Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs
|
Daniel, Mélanie Y. |
|
|
22 |
10 |
p. 2702-2712 |
artikel |
29 |
Understanding the difference between type I and type II antiprothrombin antibodies and their effect on activated protein C resistance
|
Pozzi, Nicola |
|
|
22 |
10 |
p. 2935-2938 |
artikel |
30 |
Utility of thromboelastography with platelet mapping for monitoring platelet transfusion in qualitative platelet disorders
|
Lee, Robert H. |
|
|
22 |
10 |
p. 2873-2878 |
artikel |
31 |
Vascular endothelial-cadherin is involved in endothelial cell detachment during thrombotic thrombocytopenic purpura
|
Cauchois, Raphael |
|
|
22 |
10 |
p. 2879-2888 |
artikel |